A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors

Clinical trial NCT02674555 · WITHDRAWN

Trial details

NCT number: NCT02674555
Sponsor: Astellas Pharma Global Development, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Epidermal Growth Factor Receptor (EGFR) Mutations Solid Tumors

Start date: 2016-11-15
Primary completion: 2016-11-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.